G-Tech Medical is developing a wearable patch (GutTracker®) that continuously measures gut motility—an often-overlooked parameter in gastrointestinal disease. Early findings show motility is 20–30% lower during IBD flares, suggesting it could serve as a real-time indicator of disease activity.
What makes this compelling is the shift from episodic, clinic-based assessment to continuous, remote monitoring. By capturing a patient’s unique “GutPrint” over time, the technology could help predict flares, guide therapy decisions, and even serve as an objective endpoint in drug development—potentially reducing reliance on subjective symptoms and placebo-influenced outcomes.